Insufficient scRNA-seq data for expression of HYPK at single-cell level.
Insufficient scRNA-seq data for expression of HYPK at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 256.88 | 89 / 89 | 2% | 0.03 | 17 / 901 |
ovary | 100% | 302.04 | 180 / 180 | 2% | 0.03 | 8 / 430 |
lung | 100% | 558.09 | 578 / 578 | 2% | 0.03 | 20 / 1155 |
bladder | 100% | 240.05 | 21 / 21 | 2% | 0.03 | 8 / 504 |
prostate | 100% | 421.08 | 245 / 245 | 1% | 0.02 | 4 / 502 |
stomach | 100% | 310.31 | 358 / 359 | 1% | 0.01 | 3 / 286 |
intestine | 100% | 319.44 | 964 / 966 | 1% | 0.01 | 5 / 527 |
breast | 100% | 273.20 | 458 / 459 | 1% | 0.02 | 10 / 1118 |
uterus | 100% | 286.03 | 170 / 170 | 1% | 0.01 | 3 / 459 |
thymus | 100% | 413.84 | 653 / 653 | 0% | 0.00 | 2 / 605 |
adipose | 100% | 282.92 | 1204 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 100% | 330.55 | 258 / 258 | 0% | 0 | 0 / 230 |
spleen | 100% | 386.50 | 241 / 241 | 0% | 0 | 0 / 0 |
esophagus | 99% | 246.16 | 1436 / 1445 | 1% | 0.01 | 1 / 183 |
pancreas | 99% | 174.03 | 325 / 328 | 1% | 0.01 | 1 / 178 |
skin | 100% | 261.85 | 1800 / 1809 | 0% | 0 | 0 / 472 |
liver | 99% | 181.81 | 224 / 226 | 0% | 0 | 0 / 406 |
muscle | 99% | 181.84 | 791 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 208.34 | 845 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 96% | 205.94 | 1281 / 1335 | 0% | 0 | 0 / 0 |
brain | 92% | 261.98 | 2437 / 2642 | 2% | 0.03 | 15 / 705 |
peripheral blood | 88% | 161.01 | 821 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.05 | 1 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006457 | Biological process | protein folding |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0050821 | Biological process | protein stabilization |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0015630 | Cellular component | microtubule cytoskeleton |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0044183 | Molecular function | protein folding chaperone |
GO_0005515 | Molecular function | protein binding |
Gene name | HYPK |
Protein name | Huntingtin interacting protein K Huntingtin-interacting protein K (Huntingtin yeast partner K) |
Synonyms | HSPC136 C15orf63 |
Description | FUNCTION: Component of several N-terminal acetyltransferase complexes . Inhibits the N-terminal acetylation activity of the N-terminal acetyltransferase NAA10-NAA15 complex (also called the NatA complex) . Has chaperone-like activity preventing polyglutamine (polyQ) aggregation of HTT in neuronal cells probably while associated with the NatA complex . May play a role in the NatA complex-mediated N-terminal acetylation of PCNP . . |
Accessions | J3QT56 ENST00000406925.6 [Q9NX55-2] ENST00000458412.2 ENST00000442995.4 [Q9NX55-2] Q9NX55 |